Patients with an acrolentiginous melanoma, lentigo maligna melanoma, mucosal or an ocular melanoma being of age 44+ have only a probability of carrying a BRAF mutation of only 22%. This evidence concerns the gene BRAF and lentigo maligna melanoma.